Neurotrophin receptor p75NTR mediates Huntington's disease-associated synaptic and memory dysfunction

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4411-4428

  Brito, Verónica ^a,b,c   Giralt, Albert ^a,b,c   Enriquez Barreto, Lilian ^d   Puigdellívol, Mar ^a,b,c   Suelves, Nuria ^a,b,c   Zamora Moratalla, Alfonsa ^e   Ballesteros, Jesús J ^e   Martín, Eduardo D ^e   Dominguez Iturza, Nuria ^d,f   Morales, Miguel ^d   Alberch, Jordi ^a,b,c   Ginés, Sílvia ^a,b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^d CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^e UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^f DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MICROTUBULE ASSOCIATED PROTEIN 2; NEUROTROPHIN RECEPTOR P75; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; NERVE GROWTH FACTOR RECEPTOR; TNFRSF16 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSOCIATIVE MEMORY; ASTROCYTE; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HETEROZYGOTE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOREACTIVITY; MEMORY DISORDER; MOUSE; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; SYNAPTIC DYSFUNCTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; CONFOCAL MICROSCOPY; CYTOLOGY; ELECTROPHYSIOLOGY; GENETICS; LEARNING; MALE; MEMORY; METABOLISM; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; CELLS, CULTURED; ELECTROPHYSIOLOGY; GENE KNOCK-IN TECHNIQUES; HETEROZYGOTE; HIPPOCAMPUS; HUMANS; HUNTINGTON DISEASE; LEARNING; MALE; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; NEURONS; RECEPTORS, NERVE GROWTH FACTOR; SYNAPSES;

EID: 84907495481     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI74809     Document Type: Article

References (104)

1. Foroud T, et al. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann Neurol. 1995;37(5):657-664.
2. Lawrence AD, Watkins LH, Sahakian BJ, Hodges JR, Robbins TW. Visual object and visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain. 2000;123(pt 7):1349-1364.
3. Lemiere J, Decruyenaere M, Evers-Kiebooms G, Vandenbussche E, Dom R. Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation - a longitudinal follow-up study. J Neurol. 2004;251(8):935-942.
4. Bäckman L, Robins-Wahlin TB, Lundin A, Ginovart N, Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers brain volumes. Brain. 1997;120(pt 12):2207-2217.
5. Watkins LH, Rogers RD, Lawrence AD, Sahakian BJ, Rosser AE, Robbins TW. Impaired planning but intact decision making in early Huntington's disease: implications for specific fronto-striatal pathology. Neuropsychologia. 2000;38(8):1112-1125.
6. Giralt A, Saavedra A, Alberch J, Pérez-Navarro E. Cognitive dysfunction in Huntington's disease: humans, mouse models and molecular mechanisms. J Huntingtons Dis. 2012;1(2):155-173.
7. Ille R, et al. Emotion recognition and experience in Huntington disease: a voxel-based morphometry study. J Psychiatry Neurosci. 2011;36(3):383-390.
8. Paulsen JS, Smith MM, Long JD, PREDICT HD investigators Coordinators of the Huntington Study Group. Cognitive decline in prodromal Huntington disease: implications for clinical trials. J Neurol Neurosurg Psychiatry. 2013;84(11):1233-1239.
9. Van Den Bogaard SJ, et al. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy-results from the TRACK-HD study. J Neurol Sci. 2011;307(1-2):60-68.
10. Berrios GE, Wagle AC, Markova IS, Wagle SA, Rosser A, Hodges JR. Psychiatric symptomsin neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects. Acta Psychiatr Scand. 2002;105(3):224-230.
11. Majerová V, et al. Disturbance of real space navigation in moderately advanced but not in early Huntington's disease. J Neurol Sci. 2012;312(1-2):86-91.
12. Herndon ES, Hladik CL, Shang P, Burns DK, Raisanen J, White CL 3rd. Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains. J Neuropathol Exp Neurol. 2009;68(3):250-261.
13. Giralt A, Saavedra A, Carretón O, Xifró X, Alberch J, Pérez-Navarro E. Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease. Hum Mol Genet. 2011;20(21):4232-4247.
14. Lynch G, et al. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease. J Neurosci. 2007;27(16):4424-4434.
15. Giralt A, et al. Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity. Hum Mol Genet. 2012;21(6):1203-1216.
16. Simmons DA, et al. Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice. Proc Natl Acad Sci U S A. 2009;106(12):4906-4911.
17. Spires TL, et al. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice. Eur J Neurosci. 2004;19(10):2799-2807.
18. Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci. 2005;6(8):603-614.
19. Woo NH, Lu B. BDNF in synaptic plasticity and memory. In: Malenka R, ed. Intracellular Communication In The Nervous System. Bethesda, Maryland, USA: NIH; 2009:135-143.
20. Yoshii A, Constantine-Paton M. Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Dev Neurobiol. 2010;70(5):304-322.
21. Barrett GL, et al. Enhanced spatial memory and hippocampal long-term potentiation in p75 neurotrophin receptor knockout mice. Hippocampus. 2010;20(1):145-152.
22. Greferath U, Bennie A, Kourakis A, Bartlett PF, Murphy M, Barrett GL. Enlarged cholinergic forebrain neurons and improved spatial learning in p75 knockout mice. Eur J Neurosci. 2000;12(3):885-893.
23. Woo NH, et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci. 2005;8(8):1069-1077.
24. Zagrebelsky M, Holz A, Dechant G, Barde YA, Bonhoeffer T, Korte M. The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J Neurosci. 2005;25(43):9989-9999.
25. Yamashita T, Tucker KL, Barde YA. Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron. 1999;24(3):585-593.
26. Hu XY, Zhang HY, Qin S, Xu H, Swaab DF, Zhou JN. Increased p75 (NTR) expression in hippocampal neurons containing hyperphosphorylated tau in Alzheimer patients. Exp Neurol. 2002;178(1):104-111.
27. Knowles JK, et al. The p75 neurotrophin receptor promotes amyloid-beta (1-42)-induced neuritic dystrophy in vitro and in vivo. J Neurosci. 2009;29(34):10627-10637.
28. Knowles JK, et al. Small molecule p75NTR ligand prevents cognitive deficits and neurite degeneration in an Alzheimer's mouse model. Neurobiol Aging. 2013;34(8):2052-2063.
29. Yang T, et al. Small molecule, non-peptide p75 ligands inhibit Aβ-induced neurodegeneration and synaptic impairment. PLoS One. 2008;3(11):e3604.
30. Brito V, Puigdellívol M, Giralt A, Del Toro D, Alberch J, Ginés S. Imbalance of p75 (NTR)/TrkB protein expression in Huntington's disease: implication for neuroprotective therapies. Cell Death Dis. 2013;4:e595.
31. Kim J, Bordiuk OL, Ferrante RJ. Experimental models of HD and reflection on therapeutic strategies. Int Rev Neurobiol. 2011;98:419-481.
32. Kommaddi RP, Dickson KM, Barker PA. Stressinduced expression of the p75 neurotrophin receptor is regulated by O-GlcNAcylation of the Sp1 transcription factor. J Neurochem. 2011;116(3):396-405.
33. Ramos A, et al. Hypo-osmolar stress induces p75NTR expression by activating Sp1-dependent transcription. J Neurosci. 2007;27(6):1498-1506.
34. Qiu Z, et al. Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. J Biol Chem. 2006;281(24):16672-16680.
35. Michaelsen K, et al. Neurotrophin receptors TrkB. T1 and p75NTR cooperate in modulating both functional and structural plasticity in mature hippocampal neurons. Eur J Neurosci. 2010;32(11):1854-1865.
36. Cragnolini AB, Friedman WJ. The function of p75NTR in glia. Trends Neurosci. 2008;31(2):99-104.
37. Cragnolini AB, Huang Y, Gokina P, Friedman WJ. Nerve growth factor attenuates proliferation of astrocytes via the p75 neurotrophin receptor. Glia. 2009;57(13):1386-1392.
38. Giralt A, et al. Neurobehavioral characterization of Endonuclease G knockout mice reveals a new putative molecular player in the regulation of anxiety. Exp Neurol. 2013;247:122-129.
39. Tekinay AB, et al. A role for LYNX2 in anxietyrelated behavior. Proc Natl Acad Sci U S A. 2009;106(11):4477-4482.
40. Assini FL, Duzzioni M, Takahashi RN. Object location memory in mice: pharmacological validation and further evidence of hippocampal CA1 participation. Behav Brain Res. 2009;204(1):206-211.
41. Cunningham JI, Raudensky J, Tonkiss J, Yamamoto BK. MDMA pretreatment leads to mild chronic unpredictable stress-induced impairments in spatial learning. Behav Neurosci. 2009;123(5):1076-1084.
42. Deacon RM, Rawlins JN. T-maze alternation in the rodent. Nat Protoc. 2006;1(1):7-12.
43. Sharma S, Rakoczy S, Brown-Borg H. Assessment of spatial memory in mice. Life Sci. 2010;87(17-18):521-536.
44. Bachevalier J, Nemanic S. Memory for spatial location and object-place associations are differently processed by the hippocampal formation, parahippocampal areas TH/TF and perirhinal cortex. Hippocampus. 2008;18(1):64-80.
45. Albasser MM, Davies M, Futter JE, Aggleton JP. Magnitude of the object recognition deficit associated with perirhinal cortex damage in rats: Effects of varying the lesion extent and the duration of the sample period. Behav Neurosci. 2009;123(1):115-124.
46. Winters BD, Saksida LM, Bussey TJ. Object recognition memory: neurobiological mechanisms of encoding, consolidation and retrieval. Neurosci Biobehav Rev. 2008;32(5):1055-1070.
47. Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13(2):93-110.
48. Baarendse PJ, et al. Differential involvement of the dorsal hippocampus in passive avoidance in C57bl/6J and DBA/2J mice. Hippocampus. 2008;18(1):11-19.
49. Baldi E, Ambrogi LC, Sacchetti B, Tassoni G, Bucherelli C. Effects of coupled perirhinal cortex and medial septal area, fimbria-fornix, entorhinal cortex tetrodotoxin inactivations on passive avoidance consolidation in the rat. Neurosci Lett. 2000;280(2):91-94.
50. Burwell RD, Bucci DJ, Sanborn MR, Jutras MJ. Perirhinal and postrhinal contributions to remote memory for context. J Neurosci. 2004;24(49):11023-11028.
51. Milnerwood AJ, et al. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Hum Mol Genet. 2006;15(10):1690-1703.
52. Harris KM, Stevens JK. Dendritic spines of CA 1 pyramidal cells in the rat hippocampus: serial electron microscopy with reference to their biophysical characteristics. J Neurosci. 1989;9(8):2982-2997.
53. 2+ signaling in dendrites. Neuron. 2005;46(4):609-622.
54. Giralt A, et al. Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: involvement of phospholipaseCγ activity and glutamate receptor expression. Neuroscience. 2009;158(4):1234-1250.
55. Nithianantharajah J, Barkus C, Murphy M, Hannan AJ. Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice. Neurobiol Dis. 2008;29(3):490-504.
56. Colbran RJ, Brown AM. Calcium/calmodulindependent protein kinase II and synaptic plasticity. Curr Opin Neurobiol. 2004;14(3):318-327.
57. Zuccato C, Marullo M, Conforti P, MacDonald ME, Tartari M, Cattaneo E. Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease. Brain Pathol. 2008;18(2):225-238.
58. Bibb JA, et al. Severe deficiencies in dopamine signaling in presymptomatic Huntington's disease mice. Proc Natl Acad Sci U S A. 2000;97(12):6809-6814.
59. Nakayama AY, Harms MB, Luo L. Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons. J Neurosci. 2000;20(14):5329-5338.
60. Tashiro A, Yuste R. Role of Rho GTPases in the morphogenesis and motility of dendritic spines. Methods Enzymol. 2008;439:285-302.
61. Rosch H, Schweigreiter R, Bonhoeffer T, Barde YA, Korte M. The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus. Proc Natl Acad Sci U S A. 2005;102(20):7362-7367.
62. Paulsen JS, et al. Clinical and biomarker changes in premanifest Huntington disease show trial feasibility: a decade of the PREDICT-HD study. Front Aging Neurosci. 2014;6:78.
63. Tabrizi SJ, et al. Predictors of phenotypic progression and disease onset in premanifest and earlystage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 2013;12(7):637-649.
64. You SC, et al. Executive functions in premanifest Huntington's disease. Mov Disord. 2014;29(3):405-409.
65. Frodl T, et al. Reduced hippocampal volume correlates with executive dysfunctioning in major depression. J Psychiatry Neurosci. 2006;31(5):316-323.
66. Eichenbaum H. How does the hippocampus contribute to memory? Trends Cogn Sci. 2003;7(10):427-429.
67. Hampton RR, Hampstead BM, Murray EA. Selective hippocampal damage in rhesus monkeys impairs spatial memory in an open-field test. Hippocampus. 2004;14(7):808-818.
68. Nadel L. The hippocampus and space revisited. Hippocampus. 1991;1(3):221-229.
69. Wright JW, Alt JA, Turner GD, Krueger JM. Differences in spatial learning comparing transgenic p75 knockout, New Zealand Black, C57BL/6, and Swiss Webster mice. Behav Brain Res. 2004;153(2):453-458.
70. Murphy KP, et al. Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation. J Neurosci. 2000;20(13):5115-5123.
71. Niklison-Chirou MV, et al. TAp73 knockout mice show morphological and functional nervous system defects associated with loss of p75 neurotrophin receptor. Proc Natl Acad Sci U S A. 2013;110(47):18952-18957.
72. Hoshino M, et al. Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and p73. J Cell Biol. 2006;172(4):589-604.
73. Agostini M, et al. Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A. 2011;108(52):21093-21098.
74. Chakravarthy B, et al. Hippocampal membraneassociated p75NTR levels are increased in Alzheimer's disease. J Alzheimers Dis. 2012;30(3):675-684.
75. Egashira Y, Tanaka T, Soni P, Sakuragi S, Tominaga-Yoshino K, Ogura A. Involvement of the p75 (NTR) signaling pathway in persistent synaptic suppression coupled with synapse elimination following repeated long-term depression induction. J Neurosci Res. 2010;88(16):3433-3446.
76. Bloodgood BL, Sabatini BL. Neuronal activity regulates diffusion across the neck of dendritic spines. Science. 2005;310(5749):866-869.
77. Santamaria F, Wils S, De Schutter E, Augustine GJ. Anomalous diffusion in Purkinje cell dendrites caused by spines. Neuron. 2006;52(4):635-648.
78. Kasai H, Matsuzaki M, Noguchi J, Yasumatsu N, Nakahara H. Structure-stability-function relationships of dendritic spines. Trends Neurosci. 2003;26(7):360-368.
79. Kasai H, Fukuda M, Watanabe S, Hayashi-Takagi A, Noguchi J. Structural dynamics of dendritic spines in memory and cognition. Trends Neurosci. 2010;33(3):121-129.
80. Chakraborti A, Allen A, Allen B, Rosi S, Fike JR. Cranial irradiation alters dendritic spine density and morphology in the hippocampus. PLoS One. 2012;7(7):e40844.
81. Penzes P, Cahill ME, Jones KA, Van Leeuwen JE, Woolfrey KM. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci. 2011;14(3):285-293.
82. Lu B, Buck CR, Dreyfus CF, Black IB. Expression of NGF and NGF receptor mRNAs in the developing brain: evidence for local delivery and action of NGF. Exp Neurol. 1989;104(3):191-199.
83. Richardson PM, Issa VM, Riopelle RJ. Distribution of neuronal receptors for nerve growth factor in the rat. J Neurosci. 1986;6(8):2312-2321.
84. Roux PP, Barker PA. Neurotrophin signaling through the p75 neurotrophin receptor. Prog Neurobiol. 2002;67(3):203-233.
85. Bernabeu RO, Longo FM. The p75 neurotrophin receptor is expressed by adult mouse dentate progenitor cells and regulates neuronal and nonneuronal cell genesis. BMC Neurosci. 2010;11:136.
86. Dougherty KD, Milner TA. p75NTR immunoreactivity in the rat dentate gyrus is mostly within presynaptic profiles but is also found in some astrocytic and postsynaptic profiles. J Comp Neurol. 1999;407(1):77-91.
87. Rudge JS, et al. Neurotrophic factor receptors and their signal transduction capabilities in rat astrocytes. Eur J Neurosci. 1994;6(5):693-705.
88. Li Z, Van Aelst L, Cline HT. Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo. Nat Neurosci. 2000;3(1):217-225.
89. Tashiro A, Minden A, Yuste R. Regulation of dendritic spine morphology by the rho family of small GTPases: antagonistic roles of Rac and Rho. Cereb Cortex. 2000;10(10):927-938.
90. Rex CS, et al. Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J Cell Biol. 2009;186(1):85-97.
91. Yamashita T, Tohyama M. The p75 receptor acts as a displacement factor that releases Rho from Rho-GDI. Nat Neurosci. 2003;6(5):461-467.
92. Wheeler VC, et al. Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse. Hum Mol Genet. 1999;8(1):115-122.
93. Mangiarini L, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87(3):493-506.
94. Murai T, Okuda S, Tanaka T, Ohta H. Characteristics of object location memory in mice: Behavioral and pharmacological studies. Physiol Behav. 2007;90(1):116-124.
95. Marco S, et al. Suppressing aberrant GluN3A expression rescues synaptic and behavioral impairments in Huntington's disease models. Nat Med. 2013;19(8):1030-1038.
96. Ambrogi Lorenzini CG, Baldi E, Bucherelli C, Sacchetti B, Tassoni G. Role of ventral hippocampus in acquisition, consolidation and retrieval of rat's passive avoidance response memory trace. Brain Res. 1997;768(1):242-248.
97. Lorenzini CA, Baldi E, Bucherelli C, Sacchetti B, Tassoni G. Role of dorsal hippocampus in acquisition, consolidation and retrieval of rat's passive avoidance response: a tetrodotoxin functional inactivation study. Brain Res. 1996;730(1-2):32-39.
98. Bourin M, Hascoët M. The mouse light/dark box test. Eur J Pharmacol. 2003;463(1-3):55-65.
99. Yang G, Pan F, Gan WB. Stably maintained dendritic spines are associated with lifelong memories. Nature. 2009;462(7275):920-924.
100. Gratacos E, Checa N, Pérez-Navarro E, Alberch J. Brain-derived neurotrophic factor (BDNF) mediates bone morphogenetic protein-2 (BMP-2) effects on cultured striatal neurones. J Neurochem. 2001;79(4):747-755.
101. Carretón O, et al. Age-dependent decline of motor neocortex but not hippocampal performance in heterozygous BDNF mice correlates with a decrease of cortical PSD-95 but an increase of hippocampal TrkB levels. Exp Neurol. 2012;237(2):335-345.
102. Grutzendler J, Tsai J, Gan WB. Rapid labeling of neuronal populations by ballistic delivery of fluorescent dyes. Methods. 2003;30(1):79-85.
103. Enriquez-Barreto L, et al. Learning improvement after PI3K activation correlates with de novo formation of functional small spines. Front Mol Neurosci. 2014;6:54.
104. Martín ED, Buno W. Stabilization effects of extracellular ATP on synaptic efficiency and plasticity in hippocampal pyramidal neurons. Eur J Neurosci. 2005;21(4):936-944.